Johns Hopkins Drug Discovery - John Hopkins University
The Johns Hopkins Drug Discovery Program continues to work with the researchers across Johns Hopkins to research and develop tomorrow’s therapeutics for a wide range of human disorders.
Johns Hopkins, Drug Discovery, Transforming academic translational research
home,page-template,page-template-full_width,page-template-full_width-php,page,page-id-2,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-7.7,wpb-js-composer js-comp-ver-4.12.1,vc_responsive
Johns Hopkins University Drug Discovery

Transforming academic
translational research


Expertise in drug
discovery research


Developing for the future

What’s New?

Eisai and Johns Hopkins Extend Drug Discovery Collaboration with New Licensing Agreement

Click here to read more

Johns Hopkins University partnered with The University of Maryland School of Pharmacy to welcome more than 200 researchers from across both universities to the first-ever UMB-JHU Joint Symposium on Drug Discovery

Click here to read more

The Maryland Innovation Initiative (MII) has awarded $22 million to more than 200 commercialization projects to include 46 start-up companies since its inception in late 2012.

Click here to read more

Building innovative partnerships

Johns Hopkins University Drug Discovery - JHU Drug Discovery

Our HTS collaboration with Eisai and partnership with IOCB represent innovative ways to create a great synergy of complimentary organizations working together to develop new therapeutics.

Interested in Working With Us?

Johns Hopkins University Drug Discovery - JHU Drug Discovery

We welcome opportunities to discuss how we can work together in various capacities including laboratory services, drug discovery collaborations, and industrial collaborations.

Login to iLab to submit a proposal to JHDD.